Government of Sri Lanka Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2012
NCT01624064
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Ministry of Health, Sri Lanka

Active Ingredients

Drugs in Phase 2 Trials (2)

calcium (1 trial)

enalapril (vasotec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Diseases (Phase 2)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2